Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Peuskens

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 23, 2011
Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label studyMartien Wampers, Linda Hanssens, Ruud van Winkel, et al.
CNS Drugs|September 29, 2012
Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE studyChris Bervoets, Manuel Morrens, Kristof Vansteelandt, et al.
International Journal of Psychiatry in Clinical Practice|June 19, 2014
Management of acutely ill patients in the hospital setting: focus on quetiapineJoseph Peuskens, Siegfried Kasper, Celso Arango, et al.
Schizophrenia Research|August 3, 2010
Effects of cannabis use on age at onset in schizophrenia and bipolar disorderMarc De Hert, Martien Wampers, Tihana Jendricko, et al.
Schizophrenia Research|October 22, 2008
A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorderLinda Hanssens, Ruud van Winkel, Martien Wampers, et al.
Schizophrenia Research|February 27, 2008
Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart reviewMarc De Hert, Vincent Schreurs, Kim Sweers, et al.
BMC Gastroenterology|March 10, 2011
Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive studyMarc De Hert, Liesbeth Dockx, Chiara Bernagie, et al.
Neuroimage|April 30, 2013
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophreniaJenny Ceccarini, Marc De Hert, Ruud Van Winkel, et al.
Therapeutic Advances in Psychopharmacology|February 4, 2014
SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effectsPeter M Haddad, W Wolfgang Fleischhacker, Joseph Peuskens, et al.
Schizophrenia Research|November 6, 2010
Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugsTim Moons, Stephan Claes, Gerard J M Martens, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 23, 2011
Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label studyMartien Wampers, Linda Hanssens, Ruud van Winkel, et al.
CNS Drugs|September 29, 2012
Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE studyChris Bervoets, Manuel Morrens, Kristof Vansteelandt, et al.
International Journal of Psychiatry in Clinical Practice|June 19, 2014
Management of acutely ill patients in the hospital setting: focus on quetiapineJoseph Peuskens, Siegfried Kasper, Celso Arango, et al.
Schizophrenia Research|August 3, 2010
Effects of cannabis use on age at onset in schizophrenia and bipolar disorderMarc De Hert, Martien Wampers, Tihana Jendricko, et al.
Schizophrenia Research|October 22, 2008
A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorderLinda Hanssens, Ruud van Winkel, Martien Wampers, et al.
Schizophrenia Research|February 27, 2008
Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart reviewMarc De Hert, Vincent Schreurs, Kim Sweers, et al.
BMC Gastroenterology|March 10, 2011
Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive studyMarc De Hert, Liesbeth Dockx, Chiara Bernagie, et al.
Neuroimage|April 30, 2013
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophreniaJenny Ceccarini, Marc De Hert, Ruud Van Winkel, et al.
Therapeutic Advances in Psychopharmacology|February 4, 2014
SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effectsPeter M Haddad, W Wolfgang Fleischhacker, Joseph Peuskens, et al.
Schizophrenia Research|November 6, 2010
Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugsTim Moons, Stephan Claes, Gerard J M Martens, et al.
Pageof 8